BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35044110)

  • 1. Longitudinal effects of one-leg standing time on neuropathy outcomes in association with glycemic control in non-elderly patients with type 2 diabetes.
    Sugimoto K; Sozu T; Hoshino T; Watanabe Y; Tamura A; Yamazaki T; Ohta S; Suzuki S; Shimbo T
    J Diabetes Investig; 2022 Jun; 13(6):1039-1051. PubMed ID: 35044110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic peripheral neuropathy: age-stratified glycemic control.
    Wang CS; Pai YW; Lin CH; Lee IT; Chen HH; Chang MH
    Front Endocrinol (Lausanne); 2024; 15():1377923. PubMed ID: 38694945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients.
    Pan J; Yan X; Li F; Zhang Y; Jiang L; Wang C
    J Diabetes Investig; 2022 Feb; 13(2):328-335. PubMed ID: 34455710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.
    Goldman MP; Corriere MA; Craven T; Davis RP; Sheehan M; Hurie JB; Velazquez G; Williams TK; Chang K; Edwards MS
    Ann Vasc Surg; 2021 May; 73():254-263. PubMed ID: 33248240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Jun JE; Jin SM; Baek J; Oh S; Hur KY; Lee MS; Lee MK; Kim JH
    Cardiovasc Diabetol; 2015 Jun; 14():70. PubMed ID: 26041130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study.
    Ishibashi F; Kosaka A; Tavakoli M
    Front Endocrinol (Lausanne); 2022; 13():864332. PubMed ID: 35784562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy.
    Fleischer J; Laugesen E; Cichosz SL; Hoeyem P; Dejgaard TF; Poulsen PL; Tarnow L; Hansen TK
    J Diabetes Complications; 2017 Sep; 31(9):1389-1393. PubMed ID: 28728915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.
    Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Jin SM; Hur KY; Lee MK; Kim JH
    Cardiovasc Diabetol; 2017 Oct; 16(1):127. PubMed ID: 29017498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation Between Glycemic Control and Cardiac Autonomic Neuropathy in Patients With Diabetes Mellitus Type 2.
    Achmad C; Lim NS; Pramudyo M; Iqbal M; Karwiky G; Febrianora M; Natalia N
    Curr Probl Cardiol; 2023 Jul; 48(7):101135. PubMed ID: 35124077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycemic control on electrophysiologic changes of diabetic neuropathy in type 2 diabetic patients.
    Huang CC; Chen TW; Weng MC; Lee CL; Tseng HC; Huang MH
    Kaohsiung J Med Sci; 2005 Jan; 21(1):15-21. PubMed ID: 15754584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.
    Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ
    Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings.
    Qureshi MS; Iqbal M; Zahoor S; Ali J; Javed MU
    J Endocrinol Invest; 2017 Apr; 40(4):425-430. PubMed ID: 27848229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
    Mäkimattila S; Schlenzka A; Mäntysaari M; Bergholm R; Summanen P; Saar P; Erkkilä H; Yki-Järvinen H
    Diabetes Care; 2000 Nov; 23(11):1686-93. PubMed ID: 11092293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM).
    Azad N; Emanuele NV; Abraira C; Henderson WG; Colwell J; Levin SR; Nuttall FQ; Comstock JP; Sawin CT; Silbert C; Rubino FA
    J Diabetes Complications; 1999; 13(5-6):307-13. PubMed ID: 10765007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic profile variability: An independent risk factor for diabetic neuropathy in patients with type 2 diabetes.
    Firouzabadi MD; Poopak A; Sheikhy A; Samimi S; Nakhaei P; Firouzabadi FD; Moosaie F; Rabizadeh S; Nakhjavani M; Esteghamati A
    Prim Care Diabetes; 2023 Feb; 17(1):38-42. PubMed ID: 36464622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of short-term, rapid glycemic control on the peroneal nerve function and serum VCAM-1 and AGE in type 2 diabetic patients in Malaysia.
    Norlinah MI; Hamizah R; Md Isa SH; Wan Nazaimoon WM; Khalid BA
    Indian J Med Sci; 2009 Apr; 63(4):131-8. PubMed ID: 19414982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Peripheral Neuropathy Using Measurement of the Current Perception Threshold with the Neurometer® in patients with type 1 diabetes mellitus.
    Lv SL; Fang C; Hu J; Huang Y; Yang B; Zou R; Wang FY; Zhao HQ
    Diabetes Res Clin Pract; 2015 Jul; 109(1):130-4. PubMed ID: 25981398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.